Peter J. Williams
No más puestos en curso
Perfil
Peter J.
Williams worked as a Senior Director of Business Development at Millennium Pharmaceuticals from 1998 to 2004, and as a Senior Director of Business Development at Alnylam Pharmaceuticals from 2006 to 2009.
He then worked as an Associate Director at Harvard Medical School, followed by a Vice President of Business Development at ImmunoGen from 2009 to 2017.
Prior to that, he was a Vice President of Business Development at Link Medicine Corp.
in 2005.
Williams graduated from Imperial College London with a graduate degree and from the University of Sussex with an undergraduate degree.
Antiguos cargos conocidos de Peter J. Williams.
Empresas | Cargo | Fin |
---|---|---|
IMMUNOGEN, INC. | Corporate Officer/Principal | 01/12/2017 |
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Link Medicine Corp.
Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2006 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2004 |
Harvard Medical School | Corporate Officer/Principal | - |
Formación de Peter J. Williams.
University of Sussex | Undergraduate Degree |
Imperial College London | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Link Medicine Corp.
Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Peter J. Williams